IGM Biosciences (NASDAQ:IGMS) Downgraded to “Underweight” at JPMorgan Chase & Co.
JPMorgan Chase & Co. cut shares of IGM Biosciences (NASDAQ:IGMS – Free Report) from a neutral rating to an underweight rating in a research report released on Tuesday, Marketbeat reports. The brokerage currently has $9.00 target price on the stock, down from their previous target price of $12.00. Several other brokerages have also commented on […]
5 Oct 07:10 · The Cerbat Gem